Research has identified several key risk factors that require special consideration: Gastrointestinal Disorders: History of gastroparesis or delayed gastric emptying Inflammatory bowel disease Previous gastric surgery Chronic acid reflux or GERD Metabolic Conditions: Type 1 or Type 2 diabetes History of hypoglycemic episodes Thyroid disorders Adrenal insufficiency Cardiovascular Risk Factors: Existing heart rhythm disorders Uncontrolled hypertension History of cardiovascular events Researchers with these conditions should work closely with healthcare providers and consider starting with lower doses
McDonald and her colleagues are currently working to launch a multisite clinical trial to determine whether GLP-1 medications can help prevent breast cancer in women at elevated risk, including some with a history of the disease
All users can see, edit, or delete their personal information at any time (except they cannot change their username)
overweight is a BMI of 25 to 29.9, according to the U.S
La Acetil-L- (ALCAR), una forma especfica de L-carnitina, ha mostrado beneficios cognitivos y neuroprotectores
In a recent LCGC peer exchange on the topic of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), Judith Hey-Hadavi , vice president of Medical Affairs at Worldwide Clinical Trials, and Nicole Snow Pharm D, BCSCP, CSP , clinical pharmacist at Olympia Pharmaceuticals, explored the evolving landscape of GLP-1 therapies